Monday, June 6, 2011

OncoLink at ASCO
OncoLink reporters provide in-depth coverage of scientific presentations from Annual ASCO Meeting.

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013) Presenter: JM Crook Presenter's Institution: British Columbia Cancer Agency, Kelowna, BC, Canada Background Androgen-deprivation therapy (ADT) is the standard treatment for metastatic and recurrent prostate cancer, and is used frequently as...
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC) Presenter: Kian K. Ang, MD, PhD Presenter’s Institution: University of Texas M. D. Anderson Cancer Center, Houston, TX Background/Introduction The concurrent use of cisplatin or cetuximab with radiation (RT) has been shown to improve...
Cancer diagnosis as a risk factor for personal bankruptcy Presenter: Scott Ramsey Presenter’s Affiliation: Fred Hutchinson Cancer Research Center, University of Washington Background The National Institute of Health (NIH) estimates that cancer care costs in 2010 totaled $264 billion. This...
Effect of yoga on QOL, cortisol rhythm, and HRV for women with breast cancer undergoing radiotherapy Presenter: L. Cohen Presenter's Institution: University of Texas MD Anderson Cancer Center Background Yoga is an ancient practice that originated in India; this "old" practice has a new following, as complementary medicine utilization has...
Impact of out-of-pocket expenses on cancer care Presenter: Yousof Zafar Presenter Affiliation: Duke University Medical Center Background The cost of cancer treatment is high and growing rapidly. Although national media attention and public policy has focused on the cumulative costs of...
Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? Presenter: S. Domchek Presenter’s Institution: U. of Pennsylvania School of Medicine Background Research has shown that women who carry the BRCA mutations benefit from risk-reduction procedures to reduce their risk of developing breast and...
NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer Presenter: Timothy Whelan, MD Presenter's Institution: Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada Background/Introduction The majority of women with early stage breast cancer are managed with breast...
The impact of socioeconomic status on cancer care and survival Presenter: Sandra L. Wong Presenter's Affiliation: University of Michigan Background Race, less education, low income, unemployment, and lack of health insurance have all been found to be predictors for receipt of suboptimal health care. ...
Toward a rationale strategy for prostate cancer screening based on long term risk of prostate cancer metastases and death: data from a large, unscreened, population-based cohort followed for up to 30 years Presenter: H. Lilja, MD Presenter's Institution: Memorial Sloan-Kettering Cancer Center, New York, NY Background/Introduction Routine screening for prostate cancer using prostate-specific antigen (PSA) testing remains controversial. ...